Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18289101rdf:typepubmed:Citationlld:pubmed
pubmed-article:18289101lifeskim:mentionsumls-concept:C0085104lld:lifeskim
pubmed-article:18289101lifeskim:mentionsumls-concept:C1881215lld:lifeskim
pubmed-article:18289101lifeskim:mentionsumls-concept:C0725066lld:lifeskim
pubmed-article:18289101lifeskim:mentionsumls-concept:C0332185lld:lifeskim
pubmed-article:18289101pubmed:issue2lld:pubmed
pubmed-article:18289101pubmed:dateCreated2008-2-21lld:pubmed
pubmed-article:18289101pubmed:abstractTextDrug delivery systems, designed to enhance drug efficacy and reduce their adverse effects, have evolved accompanied by the development of novel materials. Nanotechnology is an emerging scientific area that has created a variety of intriguing inorganic nanoparticles. In this review, we focus on the feasibility of inorganic nanoparticles, including iron oxide nanoparticles, gold nanoparticles, fullerenes and carbon nanohorns, as drug carriers, and summarize recent advances in this field.lld:pubmed
pubmed-article:18289101pubmed:languageenglld:pubmed
pubmed-article:18289101pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18289101pubmed:citationSubsetIMlld:pubmed
pubmed-article:18289101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18289101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18289101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18289101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18289101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18289101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18289101pubmed:statusMEDLINElld:pubmed
pubmed-article:18289101pubmed:monthFeblld:pubmed
pubmed-article:18289101pubmed:issn1389-5575lld:pubmed
pubmed-article:18289101pubmed:authorpubmed-author:TsuchidaKunih...lld:pubmed
pubmed-article:18289101pubmed:authorpubmed-author:MurakamiTatsu...lld:pubmed
pubmed-article:18289101pubmed:issnTypePrintlld:pubmed
pubmed-article:18289101pubmed:volume8lld:pubmed
pubmed-article:18289101pubmed:ownerNLMlld:pubmed
pubmed-article:18289101pubmed:authorsCompleteYlld:pubmed
pubmed-article:18289101pubmed:pagination175-83lld:pubmed
pubmed-article:18289101pubmed:meshHeadingpubmed-meshheading:18289101...lld:pubmed
pubmed-article:18289101pubmed:meshHeadingpubmed-meshheading:18289101...lld:pubmed
pubmed-article:18289101pubmed:meshHeadingpubmed-meshheading:18289101...lld:pubmed
pubmed-article:18289101pubmed:meshHeadingpubmed-meshheading:18289101...lld:pubmed
pubmed-article:18289101pubmed:meshHeadingpubmed-meshheading:18289101...lld:pubmed
pubmed-article:18289101pubmed:meshHeadingpubmed-meshheading:18289101...lld:pubmed
pubmed-article:18289101pubmed:year2008lld:pubmed
pubmed-article:18289101pubmed:articleTitleRecent advances in inorganic nanoparticle-based drug delivery systems.lld:pubmed
pubmed-article:18289101pubmed:affiliationInstitute for Comprehensive Medical Science, Fujita Health University, 1-98 Dengakugakubo, Toyoake, Aichi 470-1192, Japan.lld:pubmed
pubmed-article:18289101pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18289101pubmed:publicationTypeReviewlld:pubmed
pubmed-article:18289101pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18289101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18289101lld:pubmed